TerrAscend Corp. (TSND)
Toronto Exchange · Canada · prices in CAD · close of 19 Oct 2026
Key indicators
| Last close | CAD 0.670 |
|---|---|
| 52-week range | 0.530 – 2.000 |
| Return, 1 month / 3 months | −26.4% / −11.8% |
| Return, 1 year / 3 years | −39.6% / −73.9% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 140.9% |
| Worst drawdown (1 year) | -63.2% |
| Average daily value traded | 0.16M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
TerrAscend Corp. is a cannabis company that cultivates, processes and sells cannabis products. Its range includes dried flower, pre-rolled joints, vaporizers, concentrates and edible products, sold under its own consumer brands. The company serves adult-use and medical cannabis customers through retail dispensaries and wholesale channels in the markets where it operates. TerrAscend is based in Toronto, Canada, and its business spans cultivation and manufacturing facilities as well as retail stores.
On this site TerrAscend Corp. appears as a stock on the Toronto Exchange (Canada), code TSND, with prices in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
TerrAscend Corp. (TSND) trades on the Toronto Exchange in Canada. It last closed at CAD 0.670 on 19 October 2026.
Its price-based Market X-Ray is 16 out of 100 (a weak price profile), ranking 801 of 868 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 39.6% and over the last three months it fell 11.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 14 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -25.1% | ||
| From 52-week high | -63.2% | ||
| Momentum | 21 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -11.8% | ||
| 6-month return | -24.7% | ||
| 12-month return, skipping the last month | -18.0% | ||
| Stability (higher is calmer) | 5 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 140.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -63.2% | ||
| Liquidity | 32 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.16M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −7.6% |
|---|---|
| 1 month | −26.4% |
| 3 months | −11.8% |
| 6 months | −24.7% |
| 1 year | −39.6% |
| 3 years | −73.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 0.833 / 0.895 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.046 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.